Vogt LJ, Sim-Selley LJ, Childers SR, Wiley RG, Vogt BA (2000) Distribution of mu-opioid receptors and activated G-proteins in rat cingulate cortex and alterations following removal of noradrenergic afferents. Neuroscience 2000 Abstracts 238.1. Society for Neuroscience, New Orleans, LA.
Summary: Anterior cingulate cortex (ACC) is involved in acute and chronic pain processing. Here we define opioid architecture throughout rat cingulate cortex, relate mu-opioid receptor and G-protein stimulated binding in particular layers, and localize binding to noradrenergic terminals with immunotoxin lesions (anti-DBH-saporin). [3H]DAMGO binding was highest in areas 32 and 24 with a peak in layer I. Midcingulate area 24′ and posterior area 29 had lower and homogeneous binding. DAMGO stimulated [35S]GTPγS binding in area 24′ was similar to that in areas 32 and 24, while area 29 had very low and homogeneous binding. Undercut lesions reduced [3H]DAMGO binding in all layers with greatest loss in layer I, while DAMGO-stimulated [35S]GTPγS binding losses occurred only in layers I-III. Since neurons in the midline thalamic nuclei and locus coeruleus synthesize mu-opioid receptors, noradrenergic afferents were removed with anti-DBH-saporin. This toxin reduced [3H]DAMGO binding only in layer I of areas 32 and 24, while DAMGO-stimulated [35S]GTPγS binding increased in layer II of areas 32 and 24, had no changes in area 24′, and decreased binding in layer I of area 29. Thus, in addition to their actions on ACC neurons, other sites of opiate drug actions are through mu-opioid heteroreceptors on glutamatergic thalamic and noradrenergic locus coeruleus afferents to ACC.
Related Products: Anti-DBH-SAP (Cat. #IT-03)